"To date, NNZ-2566 appears to be well-tolerated. The serious adverse events (SAEs) reported among study subjects have been typical for critically injured patients and the mortality rate is substantially below that reported in comparable trials."
#######
If they are talking about NNZ study subjects and not placebo then this is potentially a massively positive sign.
Does substantially mean statistically significant?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$17.23 |
Change
0.600(3.61%) |
Mkt cap ! $2.177B | |||
| Open | High | Low | Value | Volume |
| $16.80 | $17.34 | $16.63 | $7.954M | 464.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 180 | $17.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.23 | 198 | 5 |
View Market Depth
| Last trade - 15.57pm 31/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |